ON-013100

ON-013100 is an inhibitor of CDK used in studies of Cell Cycle Regulation and Apoptosis. In practice, this places the compound in experiments that measure checkpoint control, mitotic progression, and proliferation timing and caspase-associated cell-death signaling and survival decisions in cancer, cell cycle, and cell signaling models.

By inhibiting CDK, ON-013100 can be used to examine checkpoint control, mitotic progression, and proliferation timing and caspase-associated cell-death signaling and survival decisions. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell cycle, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CDK
• Pathway perturbation studies connected to Cell Cycle Regulation and Apoptosis
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, ON-013100 is appropriate when a defined chemical perturbant is needed to connect CDK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell cycle, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.